Successful palliative peptide receptor radionuclide therapy for impending compression of vena cava due to unresectable liver metastasis of neuroendocrine tumor

Main Article Content

Bahar Ataeinia
Christina Loberg
Hanna Kravets
Mohsen Beheshti
Dirk von Mallek
Felix M. Mottaghy
Alexander Heinzel

Abstract

We present the case of a 77 year old male patient with metastatic pancreatic neuroendocrine tumor (NET). The patient was initially treated by extensive surgical resection that however, led to severe complications with delayed recovery. During follow-up, a number of new liver metastases were detected, one of which was in segment I with impending compression of the inferior vena cava. Due to age and general condition of the patient, instead of further surgical treatment, the patient received four cycles of 177Lu-DOTATOC resulting in an overall partial response with successful tumor reduction in liver segment I, resolving an impending compression of vena cava.

Article Details

How to Cite
Ataeinia, B., Loberg, C., Kravets, H., Beheshti, M., von Mallek, D., Mottaghy, F. M., & Heinzel, A. (2019). Successful palliative peptide receptor radionuclide therapy for impending compression of vena cava due to unresectable liver metastasis of neuroendocrine tumor. EXCLI Journal, 18, 273-276. https://doi.org/10.17179/excli2019-1220
Section
Case reports